EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Umbilical Cord Wharton’s Jelly–Derived Mesenchymal Stem Cells and Their Applications in Cancer: A Systematic Review

Salsabilla Kristinawati, Adam Hermawan, Retno Murwanti

Biointerface Research in Applied Chemistry · 15.04.2026 · 16 (2)

DOI: 10.33263/briac162.049 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Biointerface Research in Applied Chemistry, online erschienen am 15.04.2026. Verfasst von Salsabilla Kristinawati und 2 weiteren Autor:innen. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells derived from Wharton’s Jelly (WJ MSCs) and their cell-free products are emerging candidates for cancer therapy but show context-dependent effects. This systematic review synthesized preclinical in vitro and in vivo evidence on the anticancer and protumorigenic roles of WJ MSCs, their secretome, and extracellular vesicles (EVs) across diverse malignancies. Searches of PubMed, Scopus, and Springer Nature Link (English, up to August 2025) followed PRISMA guidance. Experimental studies using WJ MSC-based interventions in cancer models were included, and two reviewers independently screened, extracted data, and assessed risk of bias using SYRCLE for animal studies and a QUIN-type tool for in vitro work. Twenty-six preclinical studies were eligible, predominantly in vitro with limited in vivo validation. Most reported antitumor effects—reduced proliferation, induction of apoptosis, inhibition of migration/epithelial–mesenchymal transition, and modulation of PI3K/AKT, NF κB, and STAT3 pathways—whereas a smaller subset described enhanced growth, EMT, or activation of HGF–AKT/ERK and β-catenin signaling. Overall methodological quality was moderate to high, although reporting of randomization and blinding was often incomplete. Current evidence supports WJ MSC-derived secretome and EVs as promising, potentially safer anticancer and drug-delivery platforms, but standardized production protocols, rigorous safety evaluation, and well-designed animal and clinical studies are required before clinical translation.

Zitieren

APA

Kristinawati, S., Hermawan, A., & Murwanti, R. (2026). Umbilical Cord Wharton’s Jelly–Derived Mesenchymal Stem Cells and Their Applications in Cancer: A Systematic Review. Biointerface Research in Applied Chemistry, 16(2). https://doi.org/10.33263/briac162.049

Vancouver

Kristinawati S, Hermawan A, Murwanti R. Umbilical Cord Wharton’s Jelly–Derived Mesenchymal Stem Cells and Their Applications in Cancer: A Systematic Review. Biointerface Research in Applied Chemistry. 2026;16(2). doi:10.33263/briac162.049

BibTeX
@article{Kristinawati2026,
  author = {Kristinawati, Salsabilla and Hermawan, Adam and Murwanti, Retno},
  title = {Umbilical Cord Wharton’s Jelly–Derived Mesenchymal Stem Cells and Their Applications in Cancer: A Systematic Review},
  journal = {Biointerface Research in Applied Chemistry},
  year = {2026},
  volume = {16},
  number = {2},
  doi = {10.33263/briac162.049}
}
Kostenlos starten →